Format

Send to

Choose Destination
Clin Pharmacol Ther. 2016 Mar;99(3):285-97. doi: 10.1002/cpt.318.

Leveraging big data to transform target selection and drug discovery.

Author information

1
Institute for Computational Health Sciences, University of California, San Francisco, San Francisco, California, USA.

Abstract

The advances of genomics, sequencing, and high throughput technologies have led to the creation of large volumes of diverse datasets for drug discovery. Analyzing these datasets to better understand disease and discover new drugs is becoming more common. Recent open data initiatives in basic and clinical research have dramatically increased the types of data available to the public. The past few years have witnessed successful use of big data in many sectors across the whole drug discovery pipeline. In this review, we will highlight the state of the art in leveraging big data to identify new targets, drug indications, and drug response biomarkers in this era of precision medicine.

PMID:
26659699
PMCID:
PMC4785018
DOI:
10.1002/cpt.318
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center